Zimmer’s Persona Knee Implant Clears FDA 510(k)
Zimmer’s Persona Knee Implant Clears FDA 510(k)
Introduction
Zimmer Biomet Holdings Inc. announced on October 31 that it received FDA 510(k) clearance for the Persona revision knee system used in the revision knee replacement procedures. The purpose of a 510(k) submission is to signify that a device is “substantially equivalent” to a predicate device (one that has been cleared by the FDA or marketed before 1976).
In the press release, Zimmer Biomet's vice president Todd Davis stated, "the clearance of the Persona revision knee system gives us the ability to provide surgeons with a full-service portfolio for the continuum of knee arthroplasty care, from diagnostic tools, cement spacer technologies to re-implantation solutions. The Persona revision knee system gives surgeons the flexibility to truly tailor an implant solution based on each patient’s unique anatomy for a natural fit and function.”
As of September 2018, there are 260 cases pending against Zimmer for inadequately warning patients and doctors about the adverse effects of the faulty knee implants manufactured by them. NexGen and Persona models of knee implants have been reported to fall out due to loosening of defective screws.
Comments
Latest News
Attorneys Seek Reconsideration of Talc MDL Daubert Ruling
Categories: General
Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…
Philips resolves DreamStation suits for $1.1B
Categories: Settlements
Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…
FDA OKs Generic OTC Naloxone Spray Approved by FDA
Categories: FDA Related
The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.
…